Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Oncogene
|
July 9, 2002
TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells
Sigal Gery, Charles L Sawyers, David B Agus, et al.
Molecular & Cellular Proteomics : MCP
|
May 17, 2023
An Inflection Point in Cancer Protein Biomarkers: What was and What's Next
Anna D Barker, Mario M Alba, Parag Mallick, et al.
BMC Cancer
|
July 31, 2007
A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer
Mitchell Gross, Celestia Higano, Allan Pantuck, et al.
Scientific Reports
|
May 1, 2020
Deep learned tissue "fingerprints" classify breast cancers by ER/PR/Her2 status from H&E images
Rishi R Rawat, Itzel Ortega, Preeyam Roy, et al.
BMC Research Notes
|
May 17, 2019
Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA)
Katherin Patsch, Naim Matasci, Anjana Soundararajan, et al.
Blood
|
May 3, 2002
Vaccination with CD20 peptides induces a biologically active, specific immune response in mice
Wendy K Roberts, Philip O Livingston, David B Agus, et al.
Cancer Research
|
February 18, 2010
HER kinase axis receptor dimer partner switching occurs in response to EGFR tyrosine kinase inhibition despite failure to block cellular proliferation
Anjali Jain, Elicia Penuel, Sheldon Mink, et al.
Scientific Reports
|
October 7, 2016
Single cell dynamic phenotyping
Katherin Patsch, Chi-Li Chiu, Mark Engeln, et al.
Scientific Reports
|
March 4, 2016
Intracellular kinetics of the androgen receptor shown by multimodal Image Correlation Spectroscopy (mICS)
Chi-Li Chiu, Katherin Patsch, Francesco Cutrale, et al.
Psycho-Oncology
|
June 4, 2014
Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors
Stacy A Eisenberg, Keiko Kurita, Megan Taylor-Ford, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Oncogene
|
July 9, 2002
TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells
Sigal Gery, Charles L Sawyers, David B Agus, et al.
Molecular & Cellular Proteomics : MCP
|
May 17, 2023
An Inflection Point in Cancer Protein Biomarkers: What was and What's Next
Anna D Barker, Mario M Alba, Parag Mallick, et al.
BMC Cancer
|
July 31, 2007
A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer
Mitchell Gross, Celestia Higano, Allan Pantuck, et al.
Scientific Reports
|
May 1, 2020
Deep learned tissue "fingerprints" classify breast cancers by ER/PR/Her2 status from H&E images
Rishi R Rawat, Itzel Ortega, Preeyam Roy, et al.
BMC Research Notes
|
May 17, 2019
Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA)
Katherin Patsch, Naim Matasci, Anjana Soundararajan, et al.
Blood
|
May 3, 2002
Vaccination with CD20 peptides induces a biologically active, specific immune response in mice
Wendy K Roberts, Philip O Livingston, David B Agus, et al.
Cancer Research
|
February 18, 2010
HER kinase axis receptor dimer partner switching occurs in response to EGFR tyrosine kinase inhibition despite failure to block cellular proliferation
Anjali Jain, Elicia Penuel, Sheldon Mink, et al.
Scientific Reports
|
October 7, 2016
Single cell dynamic phenotyping
Katherin Patsch, Chi-Li Chiu, Mark Engeln, et al.
Scientific Reports
|
March 4, 2016
Intracellular kinetics of the androgen receptor shown by multimodal Image Correlation Spectroscopy (mICS)
Chi-Li Chiu, Katherin Patsch, Francesco Cutrale, et al.
Psycho-Oncology
|
June 4, 2014
Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors
Stacy A Eisenberg, Keiko Kurita, Megan Taylor-Ford, et al.
Page
of 8